Pharmaceutical Formulations
OwnerAdrian Brown, Wayne M. Matthews +3inventors
InventorsAdrian Brown, Wayne M. Matthews, Daniel N. Margetson, Stephen Mark McAllister, Danielle Genevieve Rebecca Russell
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection moulding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form.
Claims35
A capsule comprising a shell having an outer surface and an opposed inner surface, the inner surface defining at least in part a confined space for holding a drug substance, or a generally cylindrical linker body having an outer surface, the shell or the linker being composed of an extruded material comprising a pharmaceutical composition comprising
- i) a low viscosity hydroxypropylcellulose (HPC) present in an amount of about 20 to about 92% w/w;
- ii) a surfactant present in an amount of about 1 to about 10% w/w;
- iii) a plasticizer present in an amount of about 1% to about 20% w/w;
- iv) a lubricant present in an amount of about 2% to about 15% w/w;
- v) at least one dissolution modifying excipient selected from a disintegrant, a soluble solid, a wicking agent or a water soluble filler, or a combination thereof;
- and wherein if the disintegrant is present it is in an amount of about 2% to about 20% w/w, and wherein if the soluble solid is present it is in an amount of about 10 to about 60% w/w, and wherein if a wicking agent is present it is in an amount of about 2.5 to about 15% w/w, and if or a water soluble filler is present it is in an amount of about 2.5 to about 20% w/w, or a combination or mixture thereof;
- and
- vi) optionally a processing aid and/or an opacifier;
- and
- wherein the shell material between and including the inner and outer surfaces is composed of the extruded and injection molded material.
A pharmaceutical composition comprising a
- i) a low viscosity grade of hydroxypropylcellulose present in an amount of about 83 to about 87% w/w;
- glycerol present in an amount of about 5% w/w;
- stearyl alcohol or stearic acid present in an amount of about 5% w/w;
- sodium dodecyl sulphate present in an amount of about 1% w/w, titanium dioxide present in an amount of about 1% w/w, hydroxypropylmethylcellose (HPMC) present in an amount of about 1% w/w;
- or
- ii) a low viscosity grade of hydroxypropylcellulose present in an amount of about 83 to about 87% w/w;
- glycerol present in an amount of about 5% w/w;
- stearyl alcohol or stearic acid present in an amount of about 5% w/w;
- sodium dodecyl sulphate present in an amount of about 1% w/w, and Opadry® or Opadry® white present in an amount of about 2% w/w.
A multi-component pharmaceutical dosage form which comprises a plurality of sub-units, each sub-unit being selected from
- a) a drug substance-containing capsule compartment which is soluble or disintegrable in a patient's gastro-intestinal environment for release of the drug substance contained in the capsule compartment, and
- b) a linker or end cap;
- and
- wherein the drug substance containing capsule, the linker or the end cap are comprised of a pharmaceutical composition comprising:
- i) a low viscosity hydroxypropylcellulose (HPC) present in an amount of about 20 to about 92% w/w;
- a surfactant present in an amount of about 1 to about 10% w/w;
- ii) a plasticizer present in an amount of about 1% to about 20% w/w;
- iii) a lubricant present in an amount of about 2% to about 15% w/w;
- iv) at least one dissolution modifying excipient selected from a disintegrant, a soluble solid, a wicking agent or a water soluble filler;
- and wherein if the disintegrant is present it is in an amount of about 2% to about 20% w/w, and wherein if the soluble solid is present it is in an amount of about 10 to about 60% w/w, and wherein if a wicking agent is present it is in an amount of about 2.5 to about 15% w/w, and if or a water soluble filler is present it is in an amount of about 2.5 to about 20% w/w or a combination or mixture thereof;
- and
- v) optionally a processing aid and/or an opacifier;
- and
- wherein the capsule compartment contains a drug substance, and in which, at least prior to administration to a patient, the sub-units are joined together in an assembled dosage form.
Dependencies are inferred from the claim text.